- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Jiuzi Holdings secures $4 million through registered direct offering | ||
| Fr | PUCT approves Entergy Texas' Cypress to Legend transmission line | ||
| Fr | First Brands Group takes steps to stabilize operations amid restructuring | ||
| Fr | CQS New City High Yield Fund to issue 1 million shares at 51.1p | ||
| Fr | Kestra Medical Technologies stock price target raised by Stifel to $30 | ||
| Fr | H.C. Wainwright raises Arcus Biosciences stock price target to $32 on lower expenses | ||
| Fr | Truist Securities lowers Arcus Biosciences stock price target on trial failure | ||
| Fr | Oxford Metrics chair Bullard purchases 37,316 shares | ||
| Fr | Tile Shop to delist from Nasdaq, implement stock splits | ||
| Fr | Pfizer declares $0.43 quarterly dividend payable in March 2026 | ||
| Fr | Nigel Wray increases stake in Sosandar to 9.5% | ||
| Fr | Jefferies raises Immunitybio stock price target to $9 on European regulatory progress | ||
| Fr | YouGov grants over 1.2 million shares under long-term incentive plan | ||
| Fr | ASOS CFO granted options under employee sharesave plan | ||
| Fr | Tirupati Graphite schedules general meeting for January 6 | ||
| Fr | Spreadex increases financial instrument holdings in Futura Medical | ||
| Fr | Bridgepoint to issue 25 million shares following OP unit exchange | ||
| Fr | Marriott Vacations Worldwide increases quarterly dividend to $0.80 | ||
| Fr | Tata Steel receives extended interim protection in Sukinda mine case | ||
| Fr | Aberdeen Group reduces voting rights in Hunting PLC below 5% | ||
| Fr | Circle receives conditional approval for national trust bank | ||
| Fr | Enova International stock price target raised to $189 from $144 at Seaport Global | ||
| Fr | Mineralys hypertension drug trial featured in JAMA's top research of 2025 | ||
| Fr | Fermi stock plunges 40% as key tenant negotiations hit snag, Stifel reports | ||
| Fr | BioCryst Pharma stock maintains Buy rating at TD Cowen on Orladeyo pediatric approval |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .